Drug Type Fusion protein, Colony-stimulating factors |
Synonyms GM1215(IL-12, IL-15,GM-CSF) |
Target |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists), IL-12 replacements(Interleukin-12 replacements), IL-15 replacements(Interleukin-15 replacements) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | US | - | |
Hematologic Neoplasms | Preclinical | US | Cytonus Therapeutics, Inc.Startup | - |
Pancreatic Carcinoma | Preclinical | US | - | |
Pancreatic Carcinoma | Preclinical | US | Cytonus Therapeutics, Inc.Startup | - |